149 related articles for article (PubMed ID: 17426087)
21. Cognitive ability in adolescents born small for gestational age: Associations with fetal growth velocity, head circumference and postnatal growth.
Jensen RB; Juul A; Larsen T; Mortensen EL; Greisen G
Early Hum Dev; 2015 Dec; 91(12):755-60. PubMed ID: 26411400
[TBL] [Abstract][Full Text] [Related]
22. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.
Räz B; Janner M; Petkovic V; Lochmatter D; Eblé A; Dattani MT; Hindmarsh PC; Flück CE; Mullis PE
J Clin Endocrinol Metab; 2008 Mar; 93(3):974-80. PubMed ID: 18029459
[TBL] [Abstract][Full Text] [Related]
23. Pituitary-gonadal function in adolescent males born appropriate or small for gestational age with or without intrauterine growth restriction.
Jensen RB; Vielwerth S; Larsen T; Greisen G; Veldhuis J; Juul A
J Clin Endocrinol Metab; 2007 Apr; 92(4):1353-7. PubMed ID: 17227800
[TBL] [Abstract][Full Text] [Related]
24. Fetal growth velocity, size in early life and adolescence, and prediction of bone mass: association to the GH-IGF axis.
Jensen RB; Vielwerth S; Frystyk J; Veldhuis J; Larsen T; Mølgaard C; Greisen G; Juul A
J Bone Miner Res; 2008 Mar; 23(3):439-46. PubMed ID: 17967132
[TBL] [Abstract][Full Text] [Related]
25. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
[TBL] [Abstract][Full Text] [Related]
26. Association of the growth hormone receptor d3-variant and catch-up growth of preterm infants with birth weight of less than 1500 grams.
Schreiner F; Stutte S; Bartmann P; Gohlke B; Woelfle J
J Clin Endocrinol Metab; 2007 Nov; 92(11):4489-93. PubMed ID: 17711923
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
28. Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.
Bianchi A; Giustina A; Cimino V; Pola R; Angelini F; Pontecorvi A; De Marinis L
J Clin Endocrinol Metab; 2009 Jun; 94(6):2015-22. PubMed ID: 19336510
[TBL] [Abstract][Full Text] [Related]
29. The -G1245A IGF1 polymorphism is related with small head size and less brain sparing in small for gestational age born children.
Ester WA; van Meurs JB; Arends NJ; Uitterlinden AG; de Ridder MA; Hokken-Koelega AC
Eur J Endocrinol; 2009 Apr; 160(4):549-55. PubMed ID: 19147602
[TBL] [Abstract][Full Text] [Related]
30. A common deletion in the growth hormone receptor gene (d3-GHR) in the offspring is related to maternal placental GH levels during pregnancy.
Jensen RB; Boas M; Nielsen JE; Maroun LL; Jørgensen A; Larsen T; Main KM; Juul A
Growth Horm IGF Res; 2020 Dec; 55():101360. PubMed ID: 33096343
[TBL] [Abstract][Full Text] [Related]
31. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
[TBL] [Abstract][Full Text] [Related]
32. Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly.
Mercado M; González B; Sandoval C; Esquenazi Y; Mier F; Vargas G; de los Monteros AL; Sosa E
J Clin Endocrinol Metab; 2008 Sep; 93(9):3411-5. PubMed ID: 18611972
[TBL] [Abstract][Full Text] [Related]
33. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
Szmit-Domagalska J; Petriczko E; Drozdzynska M; Adler G; Horodnicka-Jozwa A; Ciechanowicz A; Walczak M
Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
[TBL] [Abstract][Full Text] [Related]
34. The tumour necrosis factor (TNF)-alpha-308GA promoter polymorphism is related to prenatal growth and postnatal insulin resistance.
Casano-Sancho P; López-Bermejo A; Fernández-Real JM; Monrós E; Valls C; Rodríguez-González FX; Ricart W; Ibáñez L
Clin Endocrinol (Oxf); 2006 Feb; 64(2):129-35. PubMed ID: 16430709
[TBL] [Abstract][Full Text] [Related]
35. Cytosine-Adenosine (CA)n repeats polymorphism in IGF-I gene and early growth in infants born appropriate and small for gestational age.
Kytnarova J; Vesela K; Zlatohlavkova B; Dohnalova A; Fedorova M; Krsek M; Zeman J
Neuro Endocrinol Lett; 2009; 30(4):501-5. PubMed ID: 20010501
[TBL] [Abstract][Full Text] [Related]
36. Prediction factors in the determination of final height in subjects born small for gestational age.
Leger J; Limoni C; Collin D; Czernichow P
Pediatr Res; 1998 Jun; 43(6):808-12. PubMed ID: 9621992
[TBL] [Abstract][Full Text] [Related]
37. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
Toyoshima MT; Castroneves LA; Costalonga EF; Mendonca BB; Arnhold IJ; Jorge AA
Clin Endocrinol (Oxf); 2007 Oct; 67(4):500-4. PubMed ID: 17555512
[TBL] [Abstract][Full Text] [Related]
38. Birth size, postnatal growth and growth during growth hormone treatment in small-for-gestational-age children: associations with IGF1 gene polymorphisms and haplotypes?
Ester WA; van Meurs JB; Arends NJ; Uitterlinden AG; de Ridder MA; Hokken-Koelega AC
Horm Res; 2009; 72(1):15-24. PubMed ID: 19571555
[TBL] [Abstract][Full Text] [Related]
39. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
[TBL] [Abstract][Full Text] [Related]
40. The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.
Cinar N; Dagdelen S; Yorgun H; Canpolat U; Kabakçı G; Erbas T
Pituitary; 2015 Feb; 18(1):116-25. PubMed ID: 24706164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
